Veeva introduces trial startup software; Medivo gains access to Quest test data;

> Veeva Systems ($VEEV) introduced software to support the startup of clinical trials. Release

> Medivo struck a deal to access Quest Diagnostics' ($DGX) database of 20 billion de-identified test results. Item

> STAT profiled the work of a pair of genomics pioneers, J. Craig Venter and Feng Zhang. Feature | More

> Qiagen ($QGEN) posted data on the effectiveness of its GeneReader NGS System at detecting gene variants. News

> WIRED and Nature News looked at the trend for Silicon Valley VCs to invest in synthetic biology startups. Article | More